These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31932454)

  • 21. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.
    Kotrbová A; Ovesná P; Gybel' T; Radaszkiewicz T; Bednaříková M; Hausnerová J; Jandáková E; Minář L; Crha I; Weinberger V; Záveský L; Bryja V; Pospíchalová V
    Theranostics; 2020; 10(2):537-552. PubMed ID: 31903136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer.
    Wen W; Liang W; Wu J; Kowolik CM; Buettner R; Scuto A; Hsieh MY; Hong H; Brown CE; Forman SJ; Horne D; Morgan R; Wakabayashi M; Dellinger TH; Han ES; Yim JH; Jove R
    Mol Cancer Ther; 2014 Dec; 13(12):3037-48. PubMed ID: 25319391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt5a influences viability, migration, adhesion, colony formation, E- and N-cadherin expression of human ovarian cancer cell line SKOV-3.
    Jannesari-Ladani F; Hossein G; Monhasery N; Shahoei SH; Izadi Mood N
    Folia Biol (Praha); 2014; 60(2):57-67. PubMed ID: 24785108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment.
    Tanizaki Y; Kobayashi A; Toujima S; Shiro M; Mizoguchi M; Mabuchi Y; Yagi S; Minami S; Takikawa O; Ino K
    Cancer Sci; 2014 Aug; 105(8):966-73. PubMed ID: 24826982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
    Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
    J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
    Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells.
    Azimian-Zavareh V; Dehghani-Ghobadi Z; Ebrahimi M; Mirzazadeh K; Nazarenko I; Hossein G
    Sci Rep; 2021 Mar; 11(1):5885. PubMed ID: 33723319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RYK, a receptor of noncanonical Wnt ligand Wnt5a, is positively correlated with gastric cancer tumorigenesis and potential of liver metastasis.
    Fu Y; Chen Y; Huang J; Cai Z; Wang Y
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G352-G360. PubMed ID: 31869240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
    Bitler BG; Nicodemus JP; Li H; Cai Q; Wu H; Hua X; Li T; Birrer MJ; Godwin AK; Cairns P; Zhang R
    Cancer Res; 2011 Oct; 71(19):6184-94. PubMed ID: 21816908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
    J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
    Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively.
    Shojima K; Sato A; Hanaki H; Tsujimoto I; Nakamura M; Hattori K; Sato Y; Dohi K; Hirata M; Yamamoto H; Kikuchi A
    Sci Rep; 2015 Jan; 5():8042. PubMed ID: 25622531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis.
    Li M; Wang J; Wang C; Xia L; Xu J; Xie X; Lu W
    Exp Cell Res; 2020 Sep; 394(1):112153. PubMed ID: 32589888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation.
    Ip CK; Yung S; Chan TM; Tsao SW; Wong AS
    Oncotarget; 2014 Oct; 5(19):9133-49. PubMed ID: 25193855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer.
    Asem M; Young A; Oyama C; ClaureDeLaZerda A; Liu Y; Ravosa MJ; Gupta V; Jewell A; Khabele D; Stack MS
    Sci Rep; 2020 Jul; 10(1):11913. PubMed ID: 32681052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial-mesenchymal plasticity of human peritoneal mesothelial cells.
    Gao L; Nie X; Gou R; Hu Y; Dong H; Li X; Lin B
    J Cell Mol Med; 2021 Dec; 25(23):10916-10929. PubMed ID: 34725902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
    Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
    Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.